Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BPC-157 stands for Body Protection Compound-157
While this lists a few peptides that we offer, there are many more out there that are showing promising research and effectiveness
J Cell Biol 178(7):11011108
FOXO4-DRI is not FDA-approved and has not been tested in humans
What Reclassification Would (and Would Not) Change If BPC-157 is moved to Category 1 after the July 2026 meeting, the regulatory impact is narrower than many online summaries suggest: Scenario Category 2 (current default) Category 1 (post-reclassification) FDA approval No No 503A compounding Not permitted Permitted (pending final rulemaking) 503B outsourcing facilities Separate list (503B bulks list) Separate determination required Commercial drug product Not available Still not available without NDA Research/laboratory use Legal for research Legal for research (unchanged) In plain terms: Category 1 status lets a patient with a valid prescription get BPC-157 prepared by a state-licensed compounding pharmacy
Links in the blog are typically affiliate links that let you help support us
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
